121 related articles for article (PubMed ID: 33853084)
21. Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours.
Blažević A; Zandee WT; Franssen GJH; Hofland J; van Velthuysen MF; Hofland LJ; Feelders RA; de Herder WW
Endocr Relat Cancer; 2018 Mar; 25(3):245-254. PubMed ID: 29255095
[TBL] [Abstract][Full Text] [Related]
22. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.
Norlén O; Stålberg P; Öberg K; Eriksson J; Hedberg J; Hessman O; Janson ET; Hellman P; Åkerström G
World J Surg; 2012 Jun; 36(6):1419-31. PubMed ID: 21984144
[TBL] [Abstract][Full Text] [Related]
23. Clinical signs of fibrosis in small intestinal neuroendocrine tumours.
Daskalakis K; Karakatsanis A; Stålberg P; Norlén O; Hellman P
Br J Surg; 2017 Jan; 104(1):69-75. PubMed ID: 27861745
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms].
Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448
[TBL] [Abstract][Full Text] [Related]
25. Midgut Neuroendocrine Tumors with Liver-only Metastases: Benefit of Primary Tumor Resection.
Gangi A; Manguso N; Gong J; Crystal JS; Paski SC; Hendifar AE; Tuli R
Ann Surg Oncol; 2020 Oct; 27(11):4525-4532. PubMed ID: 32394299
[TBL] [Abstract][Full Text] [Related]
26. Impact of Mesenteric Mass in Patients With Midgut Neuroendocrine Tumors.
Malik P; Pinto C; Naparst MS; Ward SC; Aronson A; Aalberg JJ; Divino CM; Kim MK
Pancreas; 2019; 48(5):682-685. PubMed ID: 31091215
[TBL] [Abstract][Full Text] [Related]
27. Preoperative
Norlén O; Montan H; Hellman P; Stålberg P; Sundin A
World J Surg; 2018 Feb; 42(2):498-505. PubMed ID: 29159606
[TBL] [Abstract][Full Text] [Related]
28. Role of Primary Tumor Resection for Metastatic Small Bowel Neuroendocrine Tumors.
Hallet J; Law C;
World J Surg; 2021 Jan; 45(1):213-218. PubMed ID: 32797281
[TBL] [Abstract][Full Text] [Related]
29. Extent of Lymph Node Dissection for Small Bowel Neuroendocrine Tumors.
Hallet J; Law C;
World J Surg; 2021 Jan; 45(1):197-202. PubMed ID: 32737557
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
Fang C; Wang W; Zhang Y; Feng X; Sun J; Zeng Y; Chen Y; Li Y; Chen M; Zhou Z; Chen J
Chin J Cancer; 2017 Jun; 36(1):51. PubMed ID: 28637502
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Factors Associated With Progression for Advanced-Stage/G1 and G2 Small-Bowel Neuroendocrine Tumors After Multimodal Therapy: Experience From a Tertiary Referral Center.
Khetan P; Oyewole F; Wolin E; Kim MK; Divino CM
Pancreas; 2020 Apr; 49(4):509-513. PubMed ID: 32224719
[TBL] [Abstract][Full Text] [Related]
32. Hepatic surgery for metastases from neuroendocrine tumors.
Sarmiento JM; Que FG
Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
[TBL] [Abstract][Full Text] [Related]
33. Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET Study.
Lamarca A; Crona J; Ronot M; Opalinska M; Lopez Lopez C; Pezzutti D; Najran P; Carvhalo L; Franca Bezerra RO; Borg P; Vietti Violi N; Vidal Trueba H; de Mestier L; Schaefer N; Sundin A; Costa F; Pavel M; Dromain C;
Oncologist; 2019 Nov; 24(11):e1082-e1090. PubMed ID: 30910869
[TBL] [Abstract][Full Text] [Related]
34. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
Zheng M; Li Y; Li T; Zhang L; Zhou L
Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
[TBL] [Abstract][Full Text] [Related]
35. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target.
Gamboa AC; Ethun CG; Postlewait LM; Lopez-Aguiar AG; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Kooby DA; Staley CA; Cardona K; Maithel SK
Surg Oncol; 2020 Dec; 35():460-465. PubMed ID: 33080545
[TBL] [Abstract][Full Text] [Related]
36. Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital.
Folkestad O; Wasmuth HH; Mjønes P; Fougner R; Hauso Ø; Fossmark R
Surg Oncol; 2020 Dec; 35():336-343. PubMed ID: 32979699
[TBL] [Abstract][Full Text] [Related]
37. [CT and MRI findings of primary hepatic neuroendocrine neoplasm].
Li JK; Wang M; Yuan J; Song ZG
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):600-606. PubMed ID: 28835083
[No Abstract] [Full Text] [Related]
38. Impact of initial imaging with gallium-68 dotatate PET/CT on diagnosis and management of patients with neuroendocrine tumors.
Crown A; Rocha FG; Raghu P; Lin B; Funk G; Alseidi A; Hubka M; Rosales J; Lee M; Kennecke H
J Surg Oncol; 2020 Mar; 121(3):480-485. PubMed ID: 31853990
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
[TBL] [Abstract][Full Text] [Related]
40. Mesenteric tumour deposits arising from small-intestine neuroendocrine tumours are frequently associated with fibrosis and IgG4-expressing plasma cells.
Roberts J; Gonzalez RS; Revetta F; Shi C
Histopathology; 2018 Nov; 73(5):795-800. PubMed ID: 29943407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]